|
JP2874751B2
(ja)
|
1986-04-09 |
1999-03-24 |
ジェンザイム・コーポレーション |
希望する蛋白質をミルク中へ分泌する遺伝子移植動物
|
|
CN1325646C
(zh)
|
1997-10-20 |
2007-07-11 |
Gtc生物治疗学公司 |
修饰的核酸序列以及增加细胞系统中mRNA水平和蛋白质表达的方法
|
|
SE9802213D0
(sv)
*
|
1998-06-18 |
1998-06-18 |
Amersham Pharm Biotech Ab |
A method for the removal/purification of serum albumins and means for use in the method
|
|
US20030005468A1
(en)
*
|
1998-06-19 |
2003-01-02 |
Meade Harry M. |
Methods and vectors for improving nucleic acid expression
|
|
EP1115745B1
(en)
*
|
1998-09-24 |
2006-05-31 |
Pharming Intellectual Property BV |
Purification of fibrinogen from fluids by precipitation and hydrophobic interaction chromatography
|
|
DE60037397T2
(de)
*
|
1999-01-06 |
2008-06-05 |
Merrimack Pharmaceuticals, Inc., Cambridge |
Expression von ausgeschiedenem, menschlichem alpha-fetoprotein in transgenen tieren
|
|
WO2001000855A1
(en)
|
1999-06-23 |
2001-01-04 |
Ppl Therapeutics (Scotland) Ltd. |
Fusion proteins incorporating lysozyme
|
|
WO2001085192A1
(en)
*
|
2000-05-05 |
2001-11-15 |
Gtc Biotherapeutics, Inc. |
Transgenically produced decorin
|
|
US20030195707A1
(en)
*
|
2000-05-25 |
2003-10-16 |
Schork Nicholas J |
Methods of dna marker-based genetic analysis using estimated haplotype frequencies and uses thereof
|
|
US20020077775A1
(en)
*
|
2000-05-25 |
2002-06-20 |
Schork Nicholas J. |
Methods of DNA marker-based genetic analysis using estimated haplotype frequencies and uses thereof
|
|
US20040226052A1
(en)
*
|
2000-10-13 |
2004-11-11 |
Meade Harry M. |
Methods of producing a target molecule in a transgenic animal and purification of the target molecule
|
|
JP2004536081A
(ja)
*
|
2001-06-13 |
2004-12-02 |
トーラス エイチエスエイ エルエルシー |
ヒト血清アルブミンの精製
|
|
CA2456571A1
(en)
*
|
2001-08-10 |
2003-02-20 |
Genset Sa |
Human secreted proteins, their encoding polynucleotides, and uses thereof
|
|
US6875459B2
(en)
*
|
2001-09-10 |
2005-04-05 |
Henry B. Kopf |
Method and apparatus for separation of milk, colostrum, and whey
|
|
US20060253913A1
(en)
*
|
2001-12-21 |
2006-11-09 |
Yue-Jin Huang |
Production of hSA-linked butyrylcholinesterases in transgenic mammals
|
|
AU2003247354A1
(en)
*
|
2002-04-24 |
2003-11-10 |
|
Intermediate ingredient for dairy product manufacturing and method of making the same
|
|
ATE402955T1
(de)
*
|
2002-05-27 |
2008-08-15 |
Nestec Sa |
Säurelösliche proteine aus casein-micellen
|
|
GB0216001D0
(en)
*
|
2002-07-10 |
2002-08-21 |
Nat Blood Authority |
Process and composition
|
|
JP2006508062A
(ja)
*
|
2002-09-17 |
2006-03-09 |
ジーティーシー バイオセラピューティックス インコーポレイテッド |
重鎖間ジスルフィド結合を欠く免疫グロブリン分子の単離
|
|
CN1729298A
(zh)
*
|
2002-11-27 |
2006-02-01 |
Gtc生物治疗学公司 |
在乳汁中稳定生成的修饰抗体及其制备方法
|
|
US20040231010A1
(en)
*
|
2003-01-09 |
2004-11-18 |
Murray James D. |
Lysozyme transgenic ungulates
|
|
US20040210953A1
(en)
*
|
2003-01-09 |
2004-10-21 |
Murray James D. |
Lysozyme transgenic ungulates
|
|
PT1587923E
(pt)
|
2003-01-22 |
2011-12-07 |
Univ Duke |
Construções melhoradas para a expressão de polipéptidos lisossomais
|
|
AU2003261387A1
(en)
*
|
2003-02-24 |
2004-09-17 |
Gtc Biotherapeutics, Inc. |
Methods of tangential flow filtration and an apparatus therefore
|
|
WO2005085287A1
(en)
*
|
2004-03-03 |
2005-09-15 |
En-N-Tech, Inc. |
Treatments for contaminant reduction in lactoferrin preparations and lactoferrin-containing compositions
|
|
US20050197496A1
(en)
*
|
2004-03-04 |
2005-09-08 |
Gtc Biotherapeutics, Inc. |
Methods of protein fractionation using high performance tangential flow filtration
|
|
US20050245444A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Yann Echelard |
Method of using recombinant human antithrombin for neurocognitive disorders
|
|
US20060121004A1
(en)
*
|
2004-12-07 |
2006-06-08 |
Yann Echelard |
Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin
|
|
US20060130159A1
(en)
*
|
2004-12-09 |
2006-06-15 |
Nick Masiello |
Method of purifying recombinant MSP 1-42 derived from Plasmodium falciparum
|
|
US20080019905A9
(en)
*
|
2005-02-18 |
2008-01-24 |
Strome Scott E |
Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection
|
|
WO2006138647A2
(en)
*
|
2005-06-16 |
2006-12-28 |
Gtc Biotherapeutics, Inc. |
Method of making recombinant human antibodies for use in biosensor technology
|
|
WO2007014244A2
(en)
*
|
2005-07-25 |
2007-02-01 |
Gtc Biotherapeutics, Inc. |
Method of purifying recombinant human antithrombin to enhance the viral and prion safety profile
|
|
KR20080068089A
(ko)
*
|
2005-10-21 |
2008-07-22 |
지티씨바이오쎄라퓨틱스,인크. |
항체 의존성 세포 독성 활성이 증강된 항체, 그 생산 및사용 방법
|
|
US7531632B2
(en)
*
|
2006-02-16 |
2009-05-12 |
Gtc Biotherapeutics, Inc. |
Clarification of transgenic milk using depth filtration
|
|
FR2901707B1
(fr)
*
|
2006-05-31 |
2017-09-29 |
Lab Francais Du Fractionnement |
Composition de facteur vii recombinant ou transgenique, chaque molecule de facteur vii possedant deux sites de n-glycosylation a motifs glycanniques definis
|
|
CA2659809A1
(en)
*
|
2006-08-04 |
2008-02-14 |
Pharmathene Inc. |
Long half-life recombinant butyrylcholinesterase
|
|
FR2910786B1
(fr)
*
|
2006-12-29 |
2017-08-11 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies (Lfb) |
"procede d'extraction d'une proteine presente dans du lait"
|
|
JP5208428B2
(ja)
*
|
2007-01-30 |
2013-06-12 |
雪印メグミルク株式会社 |
美肌剤
|
|
FR2912310B1
(fr)
|
2007-02-13 |
2009-08-07 |
Kasan Sarl |
Nouvelles compositions cosmetiques et/ou pharmaceutiques et leurs applications.
|
|
US7919589B2
(en)
|
2007-07-10 |
2011-04-05 |
Glanbia Nutritionals (Ireland), Ltd. |
Method for removing endotoxin from proteins
|
|
TWI346666B
(en)
*
|
2007-12-31 |
2011-08-11 |
Animal Technology Inst Taiwan |
Method for seperating casein from casein-contained solution
|
|
EP2077273B1
(en)
|
2007-12-31 |
2011-09-14 |
Animal Technology Institute Taiwan |
Methods for separating casein from soluble proteins in a composition
|
|
EP2269471A4
(en)
*
|
2008-04-21 |
2012-12-26 |
Fuji Oil Co Ltd |
METHOD FOR PRODUCING DEFAMED SOYAMILPEPTIDES
|
|
WO2009134389A2
(en)
*
|
2008-05-01 |
2009-11-05 |
Gtc Biotherapeutics, Inc. |
An anti-cd137 antibody as an agent in the treatment of inflammatory conditions
|
|
CN106699869A
(zh)
*
|
2008-05-14 |
2017-05-24 |
维多利亚农业服务控股公司 |
血管生成素富集的乳级分
|
|
CN102666568B
(zh)
*
|
2009-12-18 |
2015-12-09 |
杰特有限公司 |
纯化多肽的方法
|
|
AU2010340358B2
(en)
|
2009-12-21 |
2014-07-24 |
Pharmathene, Inc. |
Recombinant butyrylcholinesterases and truncates thereof
|
|
US8861162B2
(en)
*
|
2010-03-09 |
2014-10-14 |
Honeywell International Inc. |
High power solid state power controller (SSPC) solution for primary power distribution applications
|
|
EP2813220A3
(en)
*
|
2010-04-09 |
2015-06-17 |
Pacira Pharmaceuticals, Inc. |
Method for formulating large diameter synthetic membrane vesicles
|
|
FR2958496A1
(fr)
*
|
2010-04-09 |
2011-10-14 |
Bioprotein Technologies Sa |
Preparation de proteine plasmatique de transfert des phospholipides (pltp) humaine recombinante a partir du lait d'animaux transgeniques.
|
|
CN103154233A
(zh)
*
|
2010-10-05 |
2013-06-12 |
诺沃—诺迪斯克保健股份有限公司 |
生产蛋白质的方法
|
|
US11553712B2
(en)
|
2010-12-30 |
2023-01-17 |
Laboratoire Français Du Fractionnement Et Des Biotechnologies |
Glycols as pathogen inactivating agents
|
|
KR101551298B1
(ko)
|
2011-04-01 |
2015-09-08 |
이엠디 밀리포어 코포레이션 |
나노섬유 함유 복합재료 구조
|
|
BR112014000217A2
(pt)
*
|
2011-07-07 |
2017-02-07 |
Revo Biologics Inc |
formulação e método para a criação de uma formulação que estabiliza a proteína terapêutica
|
|
TW201400499A
(zh)
|
2012-03-12 |
2014-01-01 |
Revo Biolog Inc |
抗凝血酶用於治療妊娠毒血症之用途
|
|
EP2687595B1
(en)
|
2012-07-19 |
2018-05-30 |
Laboratoire Français du Fractionnement et des Biotechnologies |
Method for purifying transgenic factor VII
|
|
BR112015002321A2
(pt)
|
2012-08-03 |
2019-10-22 |
Lfb Usa Inc |
uso de antitrombina recombinante
|
|
AR094780A1
(es)
|
2013-02-13 |
2015-08-26 |
Laboratoire Français Du Fractionnement Et Des Biotechnologies |
ANTICUERPOS ANTI-TNF-a ALTAMENTE GALACTOSILADOS Y SUS USOS
|
|
BR112015019348A2
(pt)
|
2013-02-13 |
2017-08-22 |
Lab Francais Du Fractionnement |
Métodos para produção de proteína com glicosilação modificada e com sialilação aumentada, para aumentar a atividade de sialil transferase na glândula mamária e para produzir sialil transferase, proteína com glicosilação modificada ou proteína com sialilação aumentada, composição, sialil transferase, mamífero transgênico, e, célula epitelial mamária
|
|
JP2016532100A
(ja)
|
2013-07-05 |
2016-10-13 |
ラボラトワール・フランセ・デュ・フラクシオンマン・エ・デ・ビョテクノロジーＬａｂｏｒａｔｏｉｒｅ Ｆｒａｎｃａｉｓ Ｄｕ Ｆｒａｃｔｉｏｎｎｅｍｅｎｔ Ｅｔ Ｄｅｓ Ｂｉｏｔｅｃｈｎｏｌｏｇｉｅｓ |
アフィニティークロマトグラフィーマトリックス
|
|
US9661868B2
(en)
*
|
2013-07-16 |
2017-05-30 |
Mead Johnson Nutrition Company |
Expanded bed adsorption methods for isolation of basic milk proteins including lactoferrin
|
|
JP2017520531A
(ja)
*
|
2014-06-02 |
2017-07-27 |
ラボラトワール フランセ デュ フラクショヌマン エ デ ビオテクノロジーＬａｂｏｒａｔｏｉｒｅ Ｆｒａｎｃａｉｓ ｄｕ Ｆｒａｃｔｉｏｎｎｅｍｅｎｔ ｅｔ ｄｅｓ Ｂｉｏｔｅｃｈｎｏｌｏｇｉｅｓ |
Ｆｃ断片の産生
|
|
CN112957789A
(zh)
|
2014-06-26 |
2021-06-15 |
Emd密理博公司 |
具有增强的污垢容纳能力的过滤器结构
|
|
FR3034419B1
(fr)
|
2015-04-02 |
2017-12-15 |
Lab Francais Du Fractionnement |
Procede de purification d'une proteine recombinante therapeutique a partir d'un lait transgenique
|
|
DK3283202T3
(da)
*
|
2015-04-17 |
2025-12-01 |
Emd Millipore Corp |
Fremgangsmåde til rensning af et biologisk materiale af interesse i en prøve gennem brug af ultrafiltreringsmembraner af nanofibre i tangentiel strømningsfiltreringstilstand
|
|
FR3038517B1
(fr)
|
2015-07-06 |
2020-02-28 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies |
Utilisation de fragments fc modifies en immunotherapie
|
|
US12186713B2
(en)
|
2017-07-21 |
2025-01-07 |
Merck Millipore Ltd. |
Non-woven fiber membranes
|
|
KR20210016400A
(ko)
*
|
2018-05-24 |
2021-02-15 |
지앙수 헨그루이 메디슨 컴퍼니 리미티드 |
재조합 인간 인슐린 또는 그 유사체의 전구체를 제조하는 방법
|
|
FR3082427B1
(fr)
|
2018-06-14 |
2020-09-25 |
Lab Francais Du Fractionnement |
Combinaison de facteur vii et d'un anticorps bispecifique anti-facteurs ix et x
|
|
JP7478333B2
(ja)
*
|
2020-07-29 |
2024-05-07 |
和弘 原 |
成分調整物生産装置及び成分調整物生産方法
|
|
CN113101737B
(zh)
*
|
2021-03-04 |
2023-09-15 |
京美生命科技(杭州)有限公司 |
一种亲和切向流过滤系统及其构建方法和外泌体提取方法及应用
|